Repaglinide
Composition
Single tablet of Repaglinide 0.5mg/1mg/2mg/3mg/4mg contain repaglinide I.P equivalent to Repaglinide 0.5mg/1mg/2mg/3mg/4mg
Indications
It is indicated to control blood sugar levels in type 2 diabetes
Side effects
Mild to moderate side effects have been observed such as weight gain, joint pain, diarrhea, increased urination, trouble breathing, blurred vision
Precautions
This drug is to be cautiously used in patients with kidney disease, liver disease, pregnancy, and lactation, do not drive and use machinery as this drug causes blurred vision
Contraindications
Use of this drug is contraindicated in patients with type 1 diabetes and diabetic ketoacidosis, liver dysfunction , use of clopidogrel and NPH insulin patients
Dosage and administration
In adults the usual dose consists of a tablet of 0.5 to 4mg given two to three times daily 30 minutes before a meal
Countries
We have also established roots and begun this new venture in other countries as well such as Jordan, Indonesia , and Oman
Available Forms
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai